JennyWong Ph.D.


Sydney + 61.2.8272.0572

Jenny Wong is a patent litigator who acts for clients in complex patent infringement and revocation matters. She has acted for multinational life sciences and technology companies in multijurisdictional patent disputes in the Federal Court of Australia. Her patent experience includes matters relating to human vaccines, small molecules, biosimilar monoclonal antibodies, and solar cell technology.

Jenny also advises clients on issues relating to freedom to operate and pricing and reimbursement of prescription pharmaceutical products in Australia.

Prior to joining Jones Day, Jenny worked in patent litigation at a major Australian law firm. Earlier in her career she was a post-doctoral research fellow at various research institutions, where her research focused on disease mechanisms and assessing gene expression changes in atherosclerotic cardiovascular disease, schizophrenia, and Alzheimer's disease.


  • Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirusJones Day represented Shanghai Junshi Biosciences Co., Ltd. in its strategic collaboration and license agreement with Eli Lilly and Company for the development, manufacturing, and commercialization of two antibodies for the prevention and treatment of the COVID-19 SARS-CoV-2 novel coronavirus.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.